quantisnow
FeedTopReportsPricing
⌘K
Live feed
14:59:28·549d
FDARegulatory
Alvotech logo

FDA Approval for SELARSDI issued to ALVOTECH USA INC

ALVO· Alvotech
Health Care
Original source

Companies

  • ALVO
    Alvotech
    Health Care

Recent analyst ratings

  • Dec 9UpdateBarclays$5.00
  • Nov 4UpdateDeutsche Bank$8.00
  • Oct 14UpdateMorgan Stanley$14.00
  • Sep 23UpdateDeutsche Bank$14.00
  • Feb 14UpdateUBS$18.00
  • Jan 29UpdateBarclays$17.00

Related

  • PR24d
    Alvotech Files Annual Report with the SEC
  • SEC35d
    SEC Form 6-K filed by Alvotech
  • PR36d
    Alvotech Q4 2025 and Full Year 2025 Financial Results
  • PR50d
    Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
  • SEC55d
    SEC Form 6-K filed by Alvotech
  • SEC77d
    SEC Form 6-K filed by Alvotech
  • PR77d
    Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
  • SEC80d
    SEC Form 6-K filed by Alvotech
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022